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Abstract
Desminopathy represents a subgroup of myofibrillar myopathies caused by mutations in the 
desmin gene. Three novel disease-associated mutations in the desmin gene were identified in 
unrelated Spanish families affected by cardioskeletal myopathy. A selective pattern of muscle 
involvement, which differed from that observed in myofibrillar myopathy resulting from mutations 
in the myotilin gene, was observed in each of the three families with novel mutations and each of 
three desminopathy patients with known desmin mutations. Prominent joint retractions at the 
ankles and characteristic nasal speech were observed early in the course of illness. These findings 
suggest that muscle imaging in combination with routine clinical and pathological examination 
may be helpful in distinguishing desminopathy from other forms of myofibrillar myopathy and 
ordering appropriate molecular investigations.
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1. Introduction
Desminopathies are a subgroup of myofibrillar myopathies (MFM) caused by mutations in 
the desmin gene. The disease usually presents with distal muscle weakness in the lower 
extremities eventually spreading to other muscle groups, including facial, bulbar, neck and 
respiratory muscles. Cardiomyopathy manifested with conduction blocks, arrhythmias and 
hypertrophy or dilatation of heart chambers occur in a high proportion of patients. A major 
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histological hallmark of the disease is the intracytoplasmic accumulation of desmin and 
many other proteins in muscle cells [1].
Desmin is the major intermediate filament of muscle. It is highly expressed in skeletal, 
cardiac and smooth muscles. In striated muscles, desmin localizes at the Z-lines where it 
plays a pivotal role in maintaining the structural integrity of the myofibrils by connecting 
adjacent myofibrils laterally and linking peripheral myofibrils to the sarcolemma and nuclei 
[2]. Desmin interacts with other intermediate filament proteins to form an intracytoplasmic 
network that maintains spatial relationships between the contractile apparatus and other 
structural elements of the cell [2]. Desmin is encoded by a single copy gene located in 
chromosome 2q35 band; it encompasses nine exons and codes for 476 amino acids [3]. 
Desmin molecule contains a highly conserved central alpha-helical “rod” domain flanked by 
globular N- (“head”) and C-terminal (“tail”) domains. The alpha-helical rod domain consists 
of four segments, 1A, 1B, 2A and 2B [4]. Since the first identification of mutations in the 
desmin gene in 1998, more than 25 disease-associated mutations have been reported to date 
[1]. Most of these mutations are located in the 2B region of the alpha-helical rod domain, the 
integrity of which is critically important for desmin filament assembly [5]. In this report, we 
provide a detailed description of phenotypic manifestations associated with three novel 
mutations in the desmin gene. Several recognizable phenotypic features elicited in these 
patients, including the pattern of muscle involvement, may be helpful in the diagnostic 
process and providing direction in molecular investigations. We also reviewed our previous 
desminopathy cases to validate these new findings.
2. Case reports
2.1. Family one
A 49-year-old woman presented at the age of 22 with distal weakness in the lower 
extremities and toe walking. Over the next several years, weakness spread to distal muscles 
of the upper extremities and proximal muscles of all four limbs. Difficulty swallowing and 
nasal voice were present from the onset of the disease. At the age of 46 she suffered from an 
episode of acute heart failure. Echocardiography showed mild enlargement of the left atria 
and normal morphology and function of both ventricles. 2D-Doppler examination revealed 
marked shortened deceleration time of E wave (90 ms) and annular velocity Em reduced to 
10 cm/s indicating restrictive cardiomyopathy. Two years later she experienced dizziness and 
syncopal episodes due to heart block; a permanent pacemaker was inserted. On examination, 
deep tendon reflexes were hypoactive and absent at the ankles. She had marked nasal 
speech, and muscle weakness and atrophy in all limbs, more pronounced in the anterior 
compartment of legs, the wrist, finger extensors and hand muscles. Facial, neck and trunk 
muscles were not involved. The patient had prominent contractures at the ankles and at the 
long finger flexors (Fig. 1). CK levels were twice the normal value, and EMG examination 
showed a myopathic pattern with spontaneous activity at rest. Nerve conduction studies were 
normal.
The patient’s parents, brother and daughter were unaffected. Her 25-year-old son 
complained of toe walking and swallowing difficulties from the age of 22 years. At the age 
of 24, he was diagnosed with hypertrophic cardiomyopathy. On examination, he had marked 
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nasal speech, bilateral heel cord contractures, and mild rigidity of the spine, as well as mild 
distal muscle weakness in each limb and trunk muscles. CK levels were four times normal.
2.2. Family two
A 46-year-old woman presented around the age of 25 years with swallowing difficulties and 
nasal voice. Over the next 2 years she developed progressive lower limb weakness with 
difficulty climbing stairs, foot drop and ankle contractures. Weakness progressed to involve 
proximal and distal muscles of the upper and lower limbs. At 41 she was diagnosed with 
hypertrophic cardiomyopathy. Three years later, she developed restrictive respiratory 
insufficiency requiring nocturnal ventilator support. By the age of 43 the patient was 
wheelchair-bound. On examination, she had prominent nasal speech, and generalized muscle 
weakness involving limb, face, neck and trunk muscles. In the upper extremities, biceps, 
triceps and wrist flexors were relatively preserved, whereas in the lower extremities each 
muscle was severely involved leading to almost complete absence of muscle contraction. 
She had prominent bilateral ankle contractures. Deep tendon reflexes were hypoactive. 
Sensation was intact. Slit lamp examination revealed bilateral subcapsular posterior lens 
opacities. CK level was twice normal level, and EMG examination showed a myogenic 
pattern with prominent spontaneous activity at rest. Nerve conduction studies were normal. 
Twenty-four-hour Holter monitoring and echocardiogram revealed non-sustained cardiac 
conduction defects and concentric hypertrophy of the left ventricle. The patient’s 
grandfather, mother, brother and sister died from cardiac failure at the age of 50, 43, 33 and 
50 years, respectively. All suffered from progressive muscular weakness, marked nasal 
speech and dysphagia that started in each case around 25–35 years. According to clinical 
and Echocardiography reports they also had restrictive cardiomyopathy and cardiac 
conduction block requiring pacemaker implantation. Additionally, the affected sister had 
lens opacities, and the affected brother suffered from severe respiratory insufficiency.
2.3. Family three
A 27-year-old man presented at the age of 25 years with gait abnormality and nasal voice. A 
few months prior to admission he has been diagnosed with complete AV block and a 
pacemaker was implanted. Echocardiography revealed hypertrophic cardiomyopathy. On 
examination, he had marked nasal speech, bilateral heel cord contractures, and muscle 
weakness in distal muscles of the legs. CK levels were four times normal. Several members 
of the family, including the patient’s grandfather and father, died from cardiac failure around 
the age of 50. All of them had suffered from progressive muscular weakness, cardiac 
conduction block and restrictive cardiomyopathy.
3. Methods
3.1. DES gene analyses
3.1.1. Mutation analysis—Genomic DNA was isolated from peripheral lymphocytes and 
coding exons of the DES gene amplified using polymerase chain reaction (PCR) with 
intronic primers. PCR products were sequenced using an ABI PRISM 3100 DNA analyzer 
(Applied Biosystems, Foster City, CA). Sequences were compared to the human genomic 
DES database sequence (NM_001927) and analysed using the BCM Search Launcher 
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utilities (http://www.searchlauncher.bcm.tmc.edu/), In addition, PCR products were digested 
overnight at 37 °C with restriction endonucleases MnlI, XcmI and BsrDI and 
electrophoresed on a 10% polyacrylamide gel.
3.2. Muscle biopsy
An open biopsy was performed in the index cases of each of the three families. Samples 
were obtained from the right gastrocnemius muscle in families one and three, and the biceps 
brachii muscle in family two. The samples were immediately frozen in liquid nitrogen 
chilled iso-pentane and processed by routine histological and histo-chemical techniques and 
for desmin (Dako), dystrophin (Novocastra), αB-crystallin (Novocastra), myotilin 
(Novocastra) and ubiquitin (Dako) immunohistochemistry as described [6]. In addition, γ-
filamin immunohistochemistry was performed using a monoclonal anti-filamin C antibody 
RR90, kindly provided by van der Ven [7]. Amyloid-like deposits were visualized with 
congo Red and Thioflavine-T stains. A sample of biopsy tissue was processed for 
ultrastructural examination using standard methods.
3.3. Muscle CT scan studies
Muscle CT scan studies were performed in members of the three families and in three 
additional desminopathy patients. Axial images were obtained from the mid-tight and mid-
calf level in each patient using a helical CT scanner (HiSpeed NX/i PRO, GE Medical 
Systems Milwaukee, Wis). In each patient, the following muscles were examined:
Tight level: rectus femoris, vastus lateralis and intermedius, sartorius, gracilis, 
adductor group, semimembranosus, semitendinosus and biceps femoris. Mid-calf 
level: medial and lateral gastrocnemius, soleus, anterior tibialis and peroneal group.
A summary of clinical and genetic data of all the patients in whom CT scan studies were 
performed is provided in Table 1. Cases 5 and 6 have been reported elsewhere [8,9].
4. Results
4.1. Genetic studies
Analysis of the desmin gene in family one revealed a heterozygous T-to-C transition at 
codon 419 of exon 7 in the affected mother (patient 1-1) and son (patient 1-2) but not in the 
unaffected daughter. This mutation resulted in a replacement of proline with serine (Pro419-
Ser). This mutation generates a new cleavage site for MnlI. Using restriction analysis, the 
Pro419Ser substitution was confirmed in two affected family members and excluded in the 
unaffected member and control samples. This analysis provides strong evidence that 
Pro419Ser is the mutation causing the disease and not a coincidental polymorphism.
In patient 2, a T-to-C transition at codon 392 of DES exon 6 generated a leucine to proline 
amino acid change (Leu392Pro). This mutation creates a new XcmI restriction site. 
Restriction analysis confirmed the presence of this mutation in the patient and its absence in 
100 unrelated control individuals. DNA samples from other family members were 
unavailable.
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Analysis of desmin gene sequences in the patient of family three led to the identification of a 
heterozygous A-to-T missense mutation at codon 367. The nucleotide substitution resulted 
in codon sequence change from ATT to TTT and replacement of isoleucine with phenyl-
alanine (Ile367Phe). Restriction analysis using the BsrDI endonuclease confirmed the 
presence of this mutation in the patient and its absence in 100 unrelated spanish control 
individuals.
4.2. Muscle biopsy
Muscle pathology was similar in the three families and showed a wide variation in the size 
of fibres and increased numbers of internal nuclei. Several fibres contained patches of non-
hyaline inclusions located under the sarcolemma or within the cytoplasm, which were best 
identified on modified Gomori stain. These inclusions were devoid of ATPase and oxidative 
activity (Fig. 2). Rimmed vacuoles were present in a few fibers in patients 1 and 2, but were 
abundant in patient 3. Necrotic fibres or inflammatory cells were not observed. Congophilia 
was never observed in any of the three cases. Immunocytochemical studies revealed 
subsarcolemmal or cytoplasmic aggregates strongly immunoreactive for desmin, dystrophin, 
αB-crystallin and γ-filamin. Myotilin and ubiquitin were weakly expressed, or absent (Fig. 
3). Ultrastructural examination revealed a matrix of granulofilamentous material lying at the 
Z-line level in the three index patients (not shown).
4.3. CT scan studies
The earliest abnormalities were observed at the mid-thigh level: first in semitendinosus and 
sartorius, and later in the gracilis muscle. As the disease progressed, areas of decreased 
attenuation were also seen in the hip adductors. In advanced illness, the quadriceps femoris 
becomes affected. At the mid-calf level, initial changes were seen in the peroneal group, 
followed by the anterior tibialis and the posterior group (Fig. 4). In the later stages of illness 
all muscles, except for soleus, were completely replaced by fatty tissue.
5. Discussion
We have identified three novel missense mutations in the desmin gene – Pro419Ser, 
Leu392Pro and Ile367Phe – in unrelated Spanish families suffering from autosomal 
dominant cardiac and skeletal myopathy. These patients presented in early adulthood with 
progressive distal and proximal myopathy associated with restrictive or hypertrophic 
cardiomyopathy and conduction blocks. Although dilated cardiomyopathy has been 
considered the most common form of heart involvement in patients with desmin mutations 
[10–12], recent studies, including the present observations have demonstrated the presence 
of restrictive cardiomyopathy in several desminopathy patients [13–16]. The occurrence of 
restrictive cardiomyopathy does not seem to be mutation-specific since it has been found 
associated with mutations along the desmin molecule. Taken together these observations 
suggest that restrictive cardiomyopathy in desminopathy patients is more frequent than 
initially thought. Bulbar muscle involvement causing difficulties with swallowing and nasal 
voice was evident early in the course of illness, before the limb muscles became involved. 
Prominent joint retraction at the ankles leading to toe walking were observed in each family 
at the disease onset. Furthermore, long finger flexor contractures, which are classically 
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associated with Bethlem myopathy [17] and some cases of Emery Dreifuss muscular 
dystrophy [18], were seen in the proband of family one, and rigidity of the spine was 
observed in her son. These findings expand the phenotypic manifestations of 
desminopathies. Restrictive respiratory insufficiency requiring nocturnal ventilator support 
and lens opacities were present in members of family two. The association of skeletal 
myopathy, pharyngeal weakness, hypertrophic cardiomyopathy, respiratory disturbances, 
lens opacities and a muscle biopsy showing desmin aggregates and granulofilamentous 
material at the ultrastructural level strongly suggest a αB-crystallinopathy [19,20]. However, 
DNA sequence analysis ruled out mutations in the αB-crystallin gene [21].
CT scan studies identified a recognizable pattern of distinct muscle groups being affected 
and potentially could be a tool for detecting subclinical evidence for involvement of specific 
muscles. Thus, in the early stages of illness, a selective involvement of the semitendinosus, 
followed by involvement of the gracilis and sartorius muscles was observed at the thigh 
level. At the mid-calf level, areas of decreased attenuation were observed predominantly in 
the anterior tibialis and peroneal groups and in more advanced disease in the posterior 
group. Similar findings were observed in two unrelated patients with a previously reported 
Arg406Trp desmin mutation and in the patient with a single amino acid deletion at position 
366. This particular pattern of muscle involvement clearly differed from that observed in 
myofibrillar myopathies resulting from mutations in myotilin gene [6]. Taken together, these 
observations demonstrate that muscle imaging in combination with clinical and pathological 
examination is a useful tool for distinguishing between various forms of MFM. The 
Pro419Ser mutation newly identified in family one is located in the tail domain of the 
desmin molecule, where at least seven other pathogenic desmin mutations have been 
identified [10,22–25]. Interestingly, patients exhibiting mutations in the tail domain 
predominantly develop isolated cardiomyopathy or cardiomyopathy followed by skeletal 
involvement [25], and only in two reported patients the skeletal myopathy was the first sign 
of the disease [22] as family one of the present series. One of the tail’s major functions is 
interaction with other cytoskeletal proteins to establish a cytoplasmic intermediate filament 
network [26]. Expression studies in transfected cells with most of the desmin tail mutations 
did not prevent normal desmin assembly and network formation. However, severe 
disturbances of filament formation and filament– filament interactions have been observed 
recently [25]. By contrast, the Leu392Pro and the Ile367Phe mutations found in families two 
and three, respectively, are located in the 2B region of the alpha-helical rod domain, which 
has been shown to be a hot-spot for mutations [1]. Similarly to several other mutations 
previously found in this region, the Leu392Pro mutation introduces proline, which is known 
to be a potent helix breaker. Experimental studies demonstrated that mutant desmin is 
assembly incompetent and able to disrupt a pre-existing filamentous network, resulting in 
the accumulation of abnormal desmin aggregates [27–29]. The severity of illness caused by 
the mutations located in the 2B alpha-helical domain may be explained by structural 
relationships these mutations potentially disrupt [22]. In accordance with these previous 
observations, a much more disabling disease was observed in the patient with the Leu392Pro 
mutation than in the patient with the Pro419Ser mutation.
In conclusion, this report adds to the definition of desminopathy phenotype by establishing a 
selective pattern of muscle involvement, the presence of prominent joint retraction at the 
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ankles, and characteristic nasal speech early in the course of illness. Muscle imaging may be 
helpful in distinguishing desminopathy from other forms of MFM.
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Clinical findings in the index case of family one (patient 1-1), showing weakness and 
wasting in the lower extremites (A), and contractures at the Achilles tendons (B) and long 
finger flexors (C).
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Cryostat consecutive sections stained with modified Trichrome stain (A), H&E (B), NADH 
(C), and ATPase at pH 4.65 (D). Several fibers contain dark-bluish cytoplasmic inclusions 
which are devoid of oxidative and ATPase activity.
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Serial consecutive sections showing strong desmin (A), αB-crystallin (B), dystrophin (C) 
and γ-filamin (D) immunoreactivity, and weak myotilin (E), and ubiquitin (F) 
immunoreactivity.
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Muscle CT scan images of four desminopathy patients at mid-thigh (A, C, E, G) and mid-
lower-leg (B, D, F, H) levels. At the mid-tight level involvement of the semitendinosus 
(asterisk), sartorius (arrow) and gracilis (arrowhead) are seen in patient 1-1 (A), and in 
patient 6 (G). At the very early stages of illness initial changes are already seen in the same 
muscles (C and E, patients 1-2 and 4, respectively). At the mid-calf level (B, D, F and H) 
areas of decreased attenuation are patchily distributed in the peroneal group, anterior tibialis 
and later in the posterior group. (A and B: patient 1-1, 20 years after the disease onset; C and 
D: patient 1-2, 3 years after the disease onset; E and F: patient 4, 2 years after the disease 
onset; G and H: patient 6, 10 years after the disease onset).
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Table 1
Phenotypic characteristics of patients included in the present study
Family and patient identification
Patients with novel desmin mutations Patients with previously reported destin mutations
1-1 1-2 3 4 5 6 7
Age/Gender 49/F 25/M 46/F 27/M 28/F 24/M 56/F
Age at onset 25 22 25 25 15 14 36
Distal weakness Yes Yes Yes Yes Yes Yes Yes
Proximal weakness Mild No Yes No Yes Yes Yes
Nasal voice Yes Yes Yes No Yes Yes No
Ankle contracture Yes Yes Yes Yes Yes Yes Yes
AV block Yes No Yes Yes Yes Yes No
Cardiomyopathy Yes Yes Yes Yes Yes Yes No
Respiratory insufficiency No No Yes No Yes Yes Yes
Inheritance AD AD AD AD Sporadic AD AD
Mutation Pro419Ser Pro419Ser Leu392Pro Ile367Phe Arg406Trp Arg406Trp N366del
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